Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1985 1
1993 1
2000 1
2003 1
2013 1
2017 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Have treatment protocols for primary CNS lymphoma advanced in the past 10 years.
Seidel S, Schlegel U. Seidel S, et al. Expert Rev Anticancer Ther. 2019 Oct;19(10):909-915. doi: 10.1080/14737140.2019.1677157. Epub 2019 Oct 14. Expert Rev Anticancer Ther. 2019. PMID: 31594423 Review.
Areas covered: This review addresses the question if these substantial developments have led to clinically relevant therapeutic improvement for PCNSL within the last decade. Expert opinion: The high risk of neurotoxic side effects of WBRT was further substantiated, and in …
Areas covered: This review addresses the question if these substantial developments have led to clinically relevant therapeutic impro …
Who does not receive treatment for cancer?
Ward MM, Ullrich F, Matthews K, Rushton G, Goldstein MA, Bajorin DF, Hanley A, Lynch CF. Ward MM, et al. J Oncol Pract. 2013 Jan;9(1):20-6. doi: 10.1200/JOP.2012.000829. J Oncol Pract. 2013. PMID: 23633967 Free PMC article.
Logistic regression indicated that nontreatment was more common in certain cancers (ie, small-cell and non-small-cell lung/bronchial cancers and low-grade non-Hodgkin lymphoma), advanced stages, older patients, those receiving treatment recommendations at nonaccredi …
Logistic regression indicated that nontreatment was more common in certain cancers (ie, small-cell and non-small-cell lung/bronchial cancers …
Gallium nitrate in the treatment of lymphoma.
Straus DJ. Straus DJ. Semin Oncol. 2003 Apr;30(2 Suppl 5):25-33. doi: 10.1016/s0093-7754(03)00173-8. Semin Oncol. 2003. PMID: 12776257 Review.
Radioactive gallium ((67)Ga) is concentrated at sites of malignant lymphoma, Hodgkin's disease, and other tumors. Gallium nitrate has substantial single-agent activity in the treatment of patients with advanced lymphoma and has also shown activity when used i …
Radioactive gallium ((67)Ga) is concentrated at sites of malignant lymphoma, Hodgkin's disease, and other tumors. Gallium nitrate has …
Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.
Duvic M. Duvic M. Clin Lymphoma. 2000 Nov;1 Suppl 1:S51-5. doi: 10.3816/clm.2000.s.010. Clin Lymphoma. 2000. PMID: 11707865 Review.
Conservative and sequential topical therapy patients have the same survival as patients treated with aggressive chemotherapy. Hence, until curative therapy is found, therapies that keep MF in check and prevent progression to more advanced lymphoma …
Conservative and sequential topical therapy patients have the same survival as patients treated with aggressive chemotherapy. Hence, …
Management of advanced lymphoma.
Papac RJ. Papac RJ. Conn Med. 1968 Jul;32(7):525-8. Conn Med. 1968. PMID: 4874084 Review. No abstract available.
VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly.
Zinzani PL, Bendandi M, Gherlinzoni F, Mazza P, Salvucci M, Aitini E, Miggiano MC, Gozzetti A, Tura S. Zinzani PL, et al. Haematologica. 1993 Nov-Dec;78(6):378-82. Haematologica. 1993. PMID: 7513674
BACKGROUND: Age is an important factor, especially in patients with advanced lymphoma who require more intensive and extensive therapy for any possible chance of cure. In fact, attenuation of treatment to diminish treatment-related toxicity decreases the capa …
BACKGROUND: Age is an important factor, especially in patients with advanced lymphoma who require more intensive and extensive …
VP-16 in the treatment of malignant lymphomas: a report from the Swiss Group for Clinical Cancer Research (SAKK).
Cavalli F. Cavalli F. Semin Oncol. 1985 Mar;12(1 Suppl 2):33-6. Semin Oncol. 1985. PMID: 3975656
In a pilot study, researchers at The Swiss Group for Clinical Cancer Research (SAKK) treated advanced lymphoma patients with a combination of DDP/VP-16/prednisone. ...Meanwhile, various pilot studies are being conducted in non-Hodgkin's lymphoma (NHL) patient …
In a pilot study, researchers at The Swiss Group for Clinical Cancer Research (SAKK) treated advanced lymphoma patients with a …